HDAC11 displays neuropathological alterations and offers as a novel drug target for Alzheimer's disease

Documenti analoghi

• Molecular chemiluminescence imaging of misfolded proteins with a versatile and highly sensitive probe in neurodegenerative disease models
  di: Chongzhao Ran, et al.
  Pubblicazione: (2024)
• Mapping Molecular Pathways of Histone Deacetylase in Alzheimer's Disease with Large Language Model‐Driven Knowledge Discovery
  di: Aneesh Mazumder, et al.
  Pubblicazione: (2025)
• Half‐Curcumin‐Based Chemiluminescence Probes and Their Applications in Detecting Quasi‐Stable Oxidized Proteins
  di: Jun Yang, et al.
  Pubblicazione: (2024)
• Development of a New Positron Emission Tomography Imaging Radioligand Targeting RIPK1 in the Brain and Characterization in Alzheimer's Disease
  di: Ping Bai, et al.
  Pubblicazione: (2024)
• Advanced Optical Microscopic Imaging Techniques for Imaging Amyloid Beta and Deciphering Alzheimer's Disease Pathogenesis
  di: Shiju Gu, et al.
  Pubblicazione: (2025)